Nuvectis Pharma NVCT Stock
Nuvectis Pharma Price Chart
Nuvectis Pharma NVCT Financial and Trading Overview
| Nuvectis Pharma stock price | 6.38 USD |
| Previous Close | 18.21 USD |
| Open | 18 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 800 |
| Day's Range | 16.8 - 18.46 USD |
| 52 Week Range | 6.21 - 18.65 USD |
| Volume | 118.38K USD |
| Avg. Volume | 39.93K USD |
| Market Cap | 291.33M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.43 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.5 USD |
NVCT Valuation Measures
| Enterprise Value | 276.03M USD |
| Trailing P/E | N/A |
| Forward P/E | -14.444446 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 23.544632 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Nuvectis Pharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 65.90% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18.65 USD |
| 52 Week Low | 6.21 USD |
| 50-Day Moving Average | 15.85 USD |
| 200-Day Moving Average | 10.41 USD |
NVCT Share Statistics
| Avg. Volume (3 month) | 39.93K USD |
| Avg. Daily Volume (10-Days) | 72.04K USD |
| Shares Outstanding | 16.01M |
| Float | 5.64M |
| Short Ratio | 2.86 |
| % Held by Insiders | 58.10% |
| % Held by Institutions | 19.90% |
| Shares Short | 153.31K |
| Short % of Float | 2.05% |
| Short % of Shares Outstanding | 0.95% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.91% |
| Return on Equity (ttm) | -150.49% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -20191000 USD |
| Diluted EPS (ttm) | -1.47 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.47M USD |
| Total Cash Per Share (mrq) | 0.97 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.12 |
| Book Value Per Share (mrq) | 0.773 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15260000 USD |
| Levered Free Cash Flow (ttm) | -8024750 USD |
Profile of Nuvectis Pharma
| Country | United States |
| State | NJ |
| City | Fort Lee |
| Address | 1 Bridge Plaza |
| ZIP | 07024 |
| Phone | 201 614 3150 |
| Website | https://www.nuvectis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 11 |
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Q&A For Nuvectis Pharma Stock
What is a current NVCT stock price?
Nuvectis Pharma NVCT stock price today per share is 6.38 USD.
How to purchase Nuvectis Pharma stock?
You can buy NVCT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nuvectis Pharma?
The stock symbol or ticker of Nuvectis Pharma is NVCT.
Which industry does the Nuvectis Pharma company belong to?
The Nuvectis Pharma industry is Biotechnology.
How many shares does Nuvectis Pharma have in circulation?
The max supply of Nuvectis Pharma shares is 19.55M.
What is Nuvectis Pharma Price to Earnings Ratio (PE Ratio)?
Nuvectis Pharma PE Ratio is now.
What was Nuvectis Pharma earnings per share over the trailing 12 months (TTM)?
Nuvectis Pharma EPS is -1.43 USD over the trailing 12 months.
Which sector does the Nuvectis Pharma company belong to?
The Nuvectis Pharma sector is Healthcare.
Nuvectis Pharma NVCT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}